Blood stasis dispersing

Blood stasis dispersing, known in Traditional Chinese Medicine (TCM) as 'Huo Xue Hua Yu,' is a therapeutic principle rather than a specific molecular target such as a receptor or enzyme. It refers to a pharmacological strategy aimed at improving blood circulation, resolving stagnant blood, and preventing thrombus formation [National Institutes of Health (NIH)]. While it is not a single protein, the drugs and herbs categorized under this principle typically act on multiple molecular targets, including cyclooxygenase-1 (COX-1), thrombin, and various platelet receptors like P2Y12 to exert their effects [PubMed]. In a clinical context, blood stasis dispersing agents are utilized to treat conditions characterized by impaired blood flow, such as cardiovascular diseases, stroke, and chronic inflammatory disorders. Because this term represents a physiological outcome or a cluster of biological activities, it does not fit the definition of a specific therapeutic target used in structured drug discovery. Instead, it serves as a functional classification for compounds that modulate the hemostatic and fibrinolytic systems to maintain vascular patency [StatPearls].

Other names

Huo Xue Hua YuPromoting blood circulation and removing blood stasisBlood-activating and stasis-resolvingInvigorating blood and transforming stasisBlood-stasis-removing

Inhibition of platelet aggregation factors, regulation of the coagulation cascade, and improvement of hemorheological parameters to enhance blood flow and dissolve obstructions.